BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25999656)

  • 1. In-vivo outcome study of HPPH mediated PDT using singlet oxygen explicit dosimetry (SOED).
    Penjweini R; Kim MM; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2015 Mar; 9308():. PubMed ID: 25999656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling.
    Penjweini R; Kim MM; Liu B; Zhu TC
    J Biophotonics; 2016 Dec; 9(11-12):1344-1354. PubMed ID: 27653233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive Oxygen Species Explicit Dosimetry (ROSED) of a Type 1 Photosensitizer.
    Ong YH; Kim MM; Huang Z; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2018 Feb; 10476():. PubMed ID: 29861531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling.
    Penjweini R; Liu B; Kim MM; Zhu TC
    J Biomed Opt; 2015; 20(12):128003. PubMed ID: 26720883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explicit macroscopic singlet oxygen modeling for benzoporphyrin derivative monoacid ring A (BPD)-mediated photodynamic therapy.
    Kim MM; Penjweini R; Liang X; Zhu TC
    J Photochem Photobiol B; 2016 Nov; 164():314-322. PubMed ID: 27721165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species explicit dosimetry to predict tumor growth for benzoporphyrin derivative-mediated vascular photodynamic therapy.
    Sheng T; Ong YH; Guo W; Zhu T
    J Biomed Opt; 2020 Jan; 25(6):1-13. PubMed ID: 31912689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry study of PHOTOFRIN-mediated photodynamic therapy in a mouse tumor model.
    Qiu H; Kim MM; Penjweini R; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2016 Feb; 9694():. PubMed ID: 27053822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive oxygen species explicit dosimetry to predict tumor growth for BPD-mediated vascular photodynamic therapy.
    Sheng T; Ong YH; Busch TM; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2019 Feb; 10861():. PubMed ID: 31080306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
    Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
    Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen species explicit dosimetry to predict local tumor growth for Photofrin-mediated photodynamic therapy.
    Sheng T; Ong Y; Busch TM; Zhu TC
    Biomed Opt Express; 2020 Aug; 11(8):4586-4601. PubMed ID: 32923066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Singlet Oxygen Explicit Dosimetry (SOED) and Singlet Oxygen Luminescence Dosimetry (SOLD) for Photofrin-Mediated Photodynamic Therapy.
    Kim MM; Penjweini R; Gemmell NR; Veilleux I; McCarthy A; Buller GS; Hadfield RH; Wilson BC; Zhu TC
    Cancers (Basel); 2016 Dec; 8(12):. PubMed ID: 27929427
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kim MM; Penjweini R; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2015 Mar; 9308():. PubMed ID: 25999655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species explicit dosimetry to predict local tumor control for Photofrin-mediated photodynamic therapy.
    Sheng T; Ong YH; Busch TM; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2019 Feb; 10860():. PubMed ID: 31327886
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhu TC; Kim MM; Liang X; Finlay JC; Busch TM
    Photonics Lasers Med; 2015 Feb; 4(1):59-71. PubMed ID: 25927018
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Penjweini R; Kim MM; Ong YH; Zhu TC
    Phys Med Biol; 2020 Jan; 65(3):03LT01. PubMed ID: 31751964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of singlet oxygen threshold dose for PDT.
    Zhu TC; Liu B; Kim MM; McMillan D; Liang X; Finlay JC; Busch TM
    Proc SPIE Int Soc Opt Eng; 2014 Feb; 8931():. PubMed ID: 25999651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the impact of oxygen concentration and blood flow variation on photodynamic therapy.
    Penjweini R; Kim MM; Finlay JC; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2016 Feb; 9694():. PubMed ID: 27453622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of physiological parameter for macroscopic modeling of reacted singlet oxygen concentration in an
    Wang KK; Busch TM; Finlay JC; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2009 Feb; 7164():71640O. PubMed ID: 25995531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of PDT parameters for RIF and H460 tumor models during HPPH-mediated PDT.
    Liu B; Kim MM; Gallagher-Colombo SM; Busch TM; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2014 Mar; 8931():. PubMed ID: 25999649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feasibility study of singlet oxygen explicit dosmietry (SOED) of PDT by intercomparison with a singlet oxygen luminescence dosimetry (SOLD) system.
    Kim MM; Penjweini R; Gemmell NR; Veilleux I; McCarthy A; Buller G; Hadfield RH; Wilson BC; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2016 Feb; 9694():. PubMed ID: 27064489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.